Form 8-K - Current report:
SEC Accession No. 0001193125-24-256654
Filing Date
2024-11-13
Accepted
2024-11-13 08:05:33
Documents
46
Period of Report
2024-11-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d912869d8k.htm   iXBRL 8-K 33239
2 EX-99.1 d912869dex991.htm EX-99.1 97857
3 EX-99.2 d912869dex992.htm EX-99.2 40363
7 GRAPHIC g912869ex99_2s10g1.jpg GRAPHIC 101029
8 GRAPHIC g912869ex99_2s11g1.jpg GRAPHIC 115800
9 GRAPHIC g912869ex99_2s12g1.jpg GRAPHIC 114647
10 GRAPHIC g912869ex99_2s13g1.jpg GRAPHIC 85680
11 GRAPHIC g912869ex99_2s14g1.jpg GRAPHIC 116577
12 GRAPHIC g912869ex99_2s15g1.jpg GRAPHIC 124172
13 GRAPHIC g912869ex99_2s16g1.jpg GRAPHIC 87528
14 GRAPHIC g912869ex99_2s17g1.jpg GRAPHIC 81779
15 GRAPHIC g912869ex99_2s18g1.jpg GRAPHIC 89571
16 GRAPHIC g912869ex99_2s19g1.jpg GRAPHIC 108028
17 GRAPHIC g912869ex99_2s1g1.jpg GRAPHIC 51441
18 GRAPHIC g912869ex99_2s20g1.jpg GRAPHIC 106075
19 GRAPHIC g912869ex99_2s21g1.jpg GRAPHIC 129444
20 GRAPHIC g912869ex99_2s22g1.jpg GRAPHIC 79639
21 GRAPHIC g912869ex99_2s23g1.jpg GRAPHIC 124063
22 GRAPHIC g912869ex99_2s24g1.jpg GRAPHIC 98290
23 GRAPHIC g912869ex99_2s25g1.jpg GRAPHIC 104749
24 GRAPHIC g912869ex99_2s26g1.jpg GRAPHIC 80997
25 GRAPHIC g912869ex99_2s27g1.jpg GRAPHIC 103954
26 GRAPHIC g912869ex99_2s28g1.jpg GRAPHIC 95766
27 GRAPHIC g912869ex99_2s29g1.jpg GRAPHIC 93457
28 GRAPHIC g912869ex99_2s2g1.jpg GRAPHIC 171880
29 GRAPHIC g912869ex99_2s30g1.jpg GRAPHIC 136136
30 GRAPHIC g912869ex99_2s3g1.jpg GRAPHIC 144053
31 GRAPHIC g912869ex99_2s4g1.jpg GRAPHIC 92612
32 GRAPHIC g912869ex99_2s5g1.jpg GRAPHIC 122713
33 GRAPHIC g912869ex99_2s6g1.jpg GRAPHIC 104850
34 GRAPHIC g912869ex99_2s7g1.jpg GRAPHIC 101193
35 GRAPHIC g912869ex99_2s8g1.jpg GRAPHIC 83284
36 GRAPHIC g912869ex99_2s9g1.jpg GRAPHIC 78833
37 GRAPHIC g912869g1113053650381.jpg GRAPHIC 2666
  Complete submission text file 0001193125-24-256654.txt   4638006

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA mcrb-20241107.xsd EX-101.SCH 2870
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mcrb-20241107_lab.xml EX-101.LAB 17237
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mcrb-20241107_pre.xml EX-101.PRE 10826
48 EXTRACTED XBRL INSTANCE DOCUMENT d912869d8k_htm.xml XML 3507
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

EIN.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37465 | Film No.: 241451275
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)